Drug
Chlorothiazide
Chlorothiazide is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph phase_3
1
25%
Ph not_applicable
1
25%
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)
Trials by Status
enrolling_by_invitation125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
enrolling_by_invitationnot_applicable
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
NCT07568574
completedphase_4
Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure
NCT02606253
completedphase_3
Treatment of Hypertension
NCT00000484
completed
Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus
NCT00004360
Clinical Trials (4)
Showing 4 of 4 trials
NCT07568574Not Applicable
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
NCT02606253Phase 4
Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure
NCT00000484Phase 3
Treatment of Hypertension
NCT00004360
Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4